Chen Yu-Xin, Wu Yan-Ping, Zhang Yi, Ji Pei-Xuan, Hua Jing
Division of Gastroenterology and Hepatology, Shanghai, China.
Shanghai Institute of Digestive Disease, Shanghai, China.
J Gastroenterol Hepatol. 2025 Aug;40(8):2119-2133. doi: 10.1111/jgh.17033. Epub 2025 Jun 5.
Lipid metabolism reprogramming regulates cellular inflammatory and immune functions in macrophages. The effects of macrophage-specific PPARγ on lipid metabolism and oxidative stress remain unclear. This study aimed to elucidate the impact of the modulation of macrophage PPARγ expression on lipid metabolism, oxidative stress, inflammation, and the progression of nonalcoholic fatty liver disease.
RAW264.7 cells, Kupffer cells, and bone marrow-derived macrophages were exposed to saturated fatty acids to establish a NAFLD macrophage model. Techniques, including use of PPARγ agonists/antagonists, gene knockout, and gene overexpression, were applied to modulate PPARγ expression in macrophages. NAFLD mouse models were established by feeding PPARγ and PPARγ mice a high-fat diet for 16 weeks. Changes in lipid metabolism, oxidative stress, and inflammation were assessed. Primary hepatocytes were incubated with conditioned medium from RAW264.7 cells to establish conditional coculture systems.
Saturated fatty acid stimulation increased fatty acid oxidation while reducing de novo lipogenesis in RAW264.7 cells, concurrently increasing PPARγ expression. Upregulation of PPARγ in macrophages under high-fat conditions further increased fatty acid oxidation, decreased ROS production, and inhibited inflammation. Downregulation of PPARγ had the opposite effect. Moreover, PPARγ increased the transcription of the Nrf2 gene and activated the Keap1-Nrf2 pathway. PPARγ overexpression inhibited cytokine secretion in PA-incubated macrophages, subsequently affecting hepatocyte inflammation. In vivo, macrophage-specific PPARγ knockout exacerbated liver inflammation and injury in NAFLD mice.
Modulating PPARγ expression affected lipid metabolism, reduced oxidative stress, and suppressed inflammation in macrophages. The modulation of macrophage-specific PPARγ activity may represent a potential therapeutic target for NAFLD treatment.
脂质代谢重编程调节巨噬细胞中的细胞炎症和免疫功能。巨噬细胞特异性过氧化物酶体增殖物激活受体γ(PPARγ)对脂质代谢和氧化应激的影响尚不清楚。本研究旨在阐明巨噬细胞PPARγ表达调节对脂质代谢、氧化应激、炎症以及非酒精性脂肪性肝病进展的影响。
将RAW264.7细胞、库普弗细胞和骨髓来源的巨噬细胞暴露于饱和脂肪酸中以建立非酒精性脂肪性肝病巨噬细胞模型。应用包括使用PPARγ激动剂/拮抗剂、基因敲除和基因过表达等技术来调节巨噬细胞中PPARγ的表达。通过给PPARγ和PPARγ基因敲除小鼠喂食高脂饮食16周来建立非酒精性脂肪性肝病小鼠模型。评估脂质代谢、氧化应激和炎症的变化。将原代肝细胞与RAW264.7细胞的条件培养基一起孵育以建立条件共培养系统。
饱和脂肪酸刺激增加了RAW264.7细胞中的脂肪酸氧化,同时减少了从头脂肪生成,同时增加了PPARγ的表达。高脂条件下巨噬细胞中PPARγ的上调进一步增加了脂肪酸氧化,减少了活性氧的产生,并抑制了炎症。PPARγ的下调则产生相反的效果。此外,PPARγ增加了核因子E2相关因子2(Nrf2)基因的转录并激活了Kelch样ECH相关蛋白1(Keap1)-Nrf2途径。PPARγ过表达抑制了棕榈酸孵育的巨噬细胞中的细胞因子分泌,随后影响肝细胞炎症。在体内,巨噬细胞特异性PPARγ基因敲除加剧了非酒精性脂肪性肝病小鼠的肝脏炎症和损伤。
调节PPARγ表达影响脂质代谢,降低氧化应激,并抑制巨噬细胞中的炎症。巨噬细胞特异性PPARγ活性的调节可能代表非酒精性脂肪性肝病治疗的潜在治疗靶点。